Vishwanath Rao Lingappa, MD PhD
Affiliations: | 1981-2004 | Physiology and Medicine | University of California, San Francisco, San Francisco, CA |
| 2004-2021 | Prosetta Biosciences Inc |
Area:
secretory pathway, cell biology, prions, cell-free systems, protein assembly, drug discoveryGoogle:
"Vishwanath Lingappa"Bio:
undergraduate at Swarthmore College
joined Blobel lab in 1975 at Rockefeller. PhD from Rockefeller in 1979, MD from Cornell 1980
internship and residency in internal medicine at UCSF
Joined faculty at UCSF in 1981 in the Dept. of Physiology and Medicine
general medicine clinic at San Francisco General Hospital 1980-2006
retired from UCSF to found Prosetta Corporation
currently Chief Technology Officer and CoCEO of Prosetta Corporation
CEO and CTO Prosetta Biosciences 2016-present
Children
Sign in to add trainee| Ramanujan S. Hegde | grad student | MRC-LMB | |
| D Thomas Rutkowski | grad student | 2002 | UCSF |
| Carolyn M. Ott | grad student | 2004 | UCSF |
| William Skach | post-doc | 1989-1992 | OHSU |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Galli LM, Anderson MO, Gabriel Fraley J, et al. (2021) Determination of the membrane topology of PORCN, an O-acyl transferase that modifies Wnt signalling proteins. Open Biology. 11: 200400 |
| Marreiros R, Müller-Schiffmann A, Trossbach SV, et al. (2020) Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation. Proceedings of the National Academy of Sciences of the United States of America |
| Marreiros R, Müller-Schiffmann A, Bader V, et al. (2014) Viral capsid assembly as a model for protein aggregation diseases: Active processes catalyzed by cellular assembly machines comprising novel drug targets. Virus Research |
| Lingappa UF, Wu X, Macieik A, et al. (2013) Host-rabies virus protein-protein interactions as druggable antiviral targets. Proceedings of the National Academy of Sciences of the United States of America. 110: E861-8 |
| Lingappa VR, Hurt CR, Garvey E. (2013) Capsid assembly as a point of intervention for novel anti-viral therapeutics. Current Pharmaceutical Biotechnology. 14: 513-23 |
| Choi SY, Fogelgren B, Zuo X, et al. (2012) Exocyst Sec10 is involved in basolateral protein translation and translocation in the endoplasmic reticulum. Nephron. Experimental Nephrology. 120: e134-40 |
| Lingappa VR, Harrell E, Copeland K, et al. (2010) Cell-Free Protein Synthesizing Systems As Tools for Discovery of Drugs Inhibiting Viral Capsid Assembly Antiviral Research. 86: A61 |
| Copeland K, Hansen W, Asundi V, et al. (2010) Protein–Protein Interactions Occurring During HIV Capsid Assembly in a Cell-free Protein Synthesizing System Antiviral Research. 86: A22 |
| Ott CM, Akhavan A, Lingappa VR. (2007) Specific features of the prion protein transmembrane domain regulate nascent chain orientation. The Journal of Biological Chemistry. 282: 11163-71 |
| Ott CM, Lingappa VR. (2004) Signal sequences influence membrane integration of the prion protein. Biochemistry. 43: 11973-82 |